4//SEC Filing
Appajosyula Sireesh 4
Accession 0001493152-24-040439
CIK 0001861657other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 4:10 PM ET
Size
6.6 KB
Accession
0001493152-24-040439
Insider Transaction Report
Form 4
Tharimmune, Inc.THAR
Appajosyula Sireesh
DirectorCEO
Transactions
- Purchase
Common Stock
2024-10-08$1.93/sh+5,000$9,650→ 16,364 total
Holdings
- 38,889(indirect: See footnote)
Common Stock
- 304(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]38,889 shares of common stock are held indirectly by Highpoint Pharmaceuticals, LLC and 304 shares of common stock are held by Channel BioConsulting LLC. The Reporting Person is the managing member of each of Highpoint Pharmaceuticals, LLC and Channel BioConsulting LLC and in such capacity has the right to vote and dispose of the securities held by such entities.
Documents
Issuer
Tharimmune, Inc.
CIK 0001861657
Entity typeother
Related Parties
1- filerCIK 0001901565
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 4:10 PM ET
- Size
- 6.6 KB